Purchase Order 75N91024P00309
Award Date
3/25/24
Potential Completion Date
3/24/25
Potential Value
$16K
Federal Agency
National Cancer Institute
Awardee
Roche Diagnostics Corporation
Ultimate Awardee
Not listed
NAICS Category
811310 - Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Roche Diagnostics Corporation was awarded a $15,649.28 firm fixed price purchase order for maintenance agreement services by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute in Bethesda, Maryland. The contract has a period of performance through January 27, 2025 and was awarded on January 28, 2024 without a set-aside designation. Roche Diagnostics Corporation will provide maintenance for existing equipment under this contract to support the...
This is a $15,649.32 firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Roche Diagnostics Corporation. The service agreement, which has no set-aside designation, covers the supply of laboratory instruments, reagents, test kits, and associated products and services through December 2025. Roche Diagnostics, a manufacturer of in vitro diagnostics, holds several Indefinite Delivery Vehicles and Blanket...
This is a $23,500 fixed-price purchase order awarded to Roche Diagnostics Corporation by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services. The contract is not set aside. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment, is providing critical care analyzers, reagents, test kits, and associated products and services to support the National Institutes of Health's medical...
Roche Diagnostics Corporation has been awarded a $16,756.40 firm fixed price delivery order against an unspecified government-wide acquisition contract by the National Cancer Institute, a component of the Department of Health and Human Services' National Institutes of Health, to provide reagents and consumables. The contract has a period of performance from October 18, 2023 through November 17, 2023. Place of performance will be Roche's facility located in Castleton, Indiana. No set aside...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded Roche Diagnostics Corporation a one-year, firm fixed price purchase order valued at approximately $15,649 under a maintenance agreement. The contract calls for Roche to provide maintenance services in support of equipment located at the agency's facilities in Bethesda, Maryland. As the prime contractor, Roche will be responsible for ensuring the agency's diagnostic and laboratory equipment...
<p>Roche Diagnostics Corporation was awarded a $25,458.64 firm fixed price delivery order contract by the Department of Health and Human Services' National Institutes of Health National Cancer Institute for reagents and consumables. The contract has no set-aside designation and requires completion by June 9, 2023. Roche will provide the requested products to support the National Cancer Institute's biomedical research efforts from its place of performance in Castleton, Indiana.</p>
This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is a Firm Fixed Price Delivery Order worth $3,954.80 issued by the National Cancer Institute, which is a civilian agency within the Department of Health and Human Services. The award provides Roche Diagnostics, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment, with the authority to supply critical care analyzers, reagents, test kits, and associated laboratory products...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $207,035.09 firm-fixed-price purchase order to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory instruments. The purchase order is for reagents, detection kits, ancillary reagents, special stain kits, non-reagent materials, and the relocation of 5 Roche instruments by a Roche engineer/application specialist. The purchase order was...
This is a $9,734.40 firm fixed-price purchase order awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to Roche Diagnostics Corporation. The contract does not have a set-aside designation. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment, has received numerous federal contract awards, including through General Services Administration (GSA) Schedule contracts,...
This is a delivery order awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. Department of Health and Human Services, to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The $34,568.82 firm fixed-price contract has a completion date of December 9, 2019 and does not include a set-aside designation. Roche Diagnostics has received numerous federal contract awards, including through General Services...